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Currently, China is moving towards the elimination of schistosomiasis japonica. In a previous review, the factors
affecting the progress towards the elimination of transmission of schistosomiasis in China have been summarized.
Nevertheless, some factors were neglected. Hereby, we describe four other factors which may threaten the
achievement of the goal of schistosomiasis elimination in China.
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After nearly 60 years of effort, China has achieved great
success in the control of schistosomiasis japonica, and
currently, the prevalence and intensity of Schistosoma
japonicum infection have been reduced to an extremely
low level [1,2]. The elimination of this neglected tropical
parasitic disease has been, therefore, put on the govern-
mental agenda [3]. In a previous review, Zhou and col-
leagues summarized the factors affecting the progress
towards the elimination of the transmission of schistoso-
miasis japonica in China [4]. These factors, in our opinion,
may indeed have potential impact on schistosomiasis eli-
mination, and should be taken into account during the
development of the strategy targeting the elimination of the
disease in China. However, some other factors were
neglected. Hereby, we describe four other factors that
may threaten schistosomiasis elimination in China, in-
cluding political and financial support, climate change,
praziquantel resistance, and potential transmission of
African schistosomiasis.
The experiences and lessons from the past 5 decades of
schistosomiasis control in China have shown that political
will and financial support are critically important to* Correspondence: wangweijipd@163.com; wxliangyousheng@163.com
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unless otherwise stated.the effective control of the disease [5]. At the first stage
(from mid-1950s to early 1980s) of the progress of
schistosomiasis control in China, there was strong political
will among the leaders of the New China to control schisto-
somiasis, which was called “god of plague” by Chairman
Mao, the founder of the People's Republic of China. To
wipe out “god of plague”, transmission control strategy with
emphasis on control of the snail intermediate host was im-
plemented, and mass campaigns were launched with aims
to snail control by environmental modification and mollus-
ciciding. At this stage, snail habitats were greatly shrunk,
and the number of schistosomiasis cases reduced remark-
ably [6]. The introduction of praziquantel, a highly effective,
low-cost anti-schistosomiasis drug, led to the national
schistosomiasis control strategy shifting from transmission
control to morbidity control (from mid-1980s to 2003).
The governmental commitment to eliminate schistoso-
miasis and the 10-year implementation of the World Bank
Loan Project for Schistosomiasis Control (1992–2001)
that provided sufficient funds resulted in great achieve-
ments [7,8]. During this stage, Shanghai municipality,
Guangxi Autonomous Region and Fujian, Guangdong and
Zhejiang provinces achieved the national criteria for elim-
ination of schistosomiasis [9]. However, the termination of
the World Bank Loan Project for Schistosomiasis Control
led to a sharp decline in the funds allocated to schistosom-
iasis control. In addition, many anti-schistosomiasis insti-
tutions were incorporated into general centre for disease
control and prevention (CDC) systems around the yeartd. This is an Open Access article distributed under the terms of the Creative
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greatly weakened. Such a situation resulted in a resurgence
of schistosomiasis japonica in China [10,11]. In 2004,
Chinese government made schistosomiasis one of the
highest priorities in communicable disease control, and a
new integrated strategy with emphasis on the control of
infectious sources was developed to control the trans-
mission of S. japonicum [12]. The control interventions
have been made possible due to the strong governmen-
tal will to eliminate the disease by 2020 and adequate
investment in public health owing to China’s rapid eco-
nomic development, and the strategy has been shown
high effective [13-15]. By 2012, the prevalence of S.
japonicum infection in both human and livestock has
been decreased to less than 1% in most endemic coun-
ties [16]. From the history of schistosomiasis control in
China, it is considered that reduced political will and fi-
nancial support may pose a great threat to the progress
of schistosomiasis elimination [17].
Climate change has been proved a driver of the trans-
mission of vector-borne diseases [18,19], and it has been
demonstrated that schistosomiasis, a snail-borne parasitic
disease, appears to be affected by the climate change
[20,21]. In China, the geographical distribution of the snail
host O. hupensis is restricted to areas where the mean
January temperature is above 0°C [22]. The rise of
temperature may cause snail survival and reproduction
in currently non-breeding sites, resulting in the poten-
tial transmission of schistosomiasis. It was predicted
that the temperature increases by 0.9°C in 2030 and 1.6°C
in 2050 in China, which may expand schistosomiasis
transmission into currently non-endemic areas in the
north, with an additional 783883 km2 area [23], and
20.7 million people at risk of infection by 2050 [24]. It is
therefore considered that climate change may affect, in
a long-term manner, the progress of schistosomiasis
elimination in China.
Praziquantel is currently the only drug of choice for
the treatment of human schistosomiases. Evidence from
Africa and South America has shown that resistance to
praziquantel may emerge following long-term, extensive
and repeated use [25-27]. In China, praziquantel-based
chemotherapy has been implemented to control the
morbidity and reduce the prevalence and intensity of S.
japonicum infection for nearly 4 decades, and the strat-
egy has been proved highly effective [28]. There is there-
fore a great concern about the development of drug
resistance [29]. We evaluated the sensitivity of S. japoni-
cum to praziquantel in highly, moderately and lowly en-
demic regions of China, and no evidence of resistance
to praziquantel was detected [30,31]. However, there are
still some cases infected with S. japonicum in whom
standard treatment regimen fails to clear the infection
[32]. In addition, it has been proved that S. japonicumsubjected to drug pressure may develop resistance to
praziquantel [33]. The potential emergence of praziquantel
resistance would seriously threaten the elimination of schis-
tosomiasis in China, since praziquantel-based chemother-
apy is still critical to the national schistosomiasis control
program and no alternatives have been developed. Identi-
fication of populations at a high risk of praziquantel re-
sistance is of urgent need.
China is only endemic for S. japonicum. Biomphalaria
straminea, an intermediate host of S. mansoni in South
America, was first discovered in southern China in 1981
as an invasive snail species, and the snail habitants appear
extensive expansion [34]. With the continuous rise in the
detection of schistosomiasis cases caused by S. manosni
in mainland China, the likelihood of transmission of
schistosomiasis mansoni in China receives worldwide
attention [35]. The lack of highly effective diagnostics,
high mobility of the imported cases infected with S.
mansoni, and their non-specific syndromes which may
easily lead to missed diagnosis and misdiagnosis, and the
lack of a sensitive surveillance-response system make it
extremely difficult to tackle the risk of the transmission of
S. mansoni in China, which poses a threat to the progress
of schistosomiasis elimination in China [36]. Determi-
nation of the compatibility of B. straminea present in
southern China to S. mansoni, and the susceptibility of the
cercariae released from B. straminea to definitive hosts,
should be given high priority.
Although these factors may have a potential impact on
the progress towards the elimination of transmission of
schistosomiasis in China, we do believe the goal of
schistosomiasis elimination can be achieved in China by
2020 with the strong political and financial support from
the Chinese Government and enhanced multi-sector
collaborations.
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